A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT04990440 · TERMINATED
Trial details
- NCT number
- NCT04990440
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-02
- Primary completion
- 2022-03-09
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.